MTOR and osteosarcoma: In conclusion, TRIM17 regulates FTO expression by promoting post-translational ubiquitination modification of FTO protein, thereby positively modulating the AKT/mTOR signaling pathway to enhance the clonability and survival potential, migration, and invasion of osteosarcoma.